To effectively address critical questions related to the adoption and deployment of in silico methods for specific topics, the Avicenna Alliance has established dedicated Task Forces, composed of experts from various fields, ensuring a multidisciplinary approach to solving complex issues.
These groups collaborate to achieve concrete progress for matters as diverse as In silico AI, Patient involvement, Horizon Europe Projects, Pharmaceutical strategy, In silico oncology, Notified Bodies and Standard Organizations, etc.
By leveraging diverse expertise and fostering strong industry-academia relationships – each Task Force is led by 2 co-chairs one from academia and one from industry - the Task Forces aim to pave the way for widespread implementation and acceptance of in silico practices, ultimately benefiting patients and advancing scientific progress.
NEWS
Avicenna Alliance at RAPS meeting in Pittsburgh
On October 8th, various key members of the Avicenna Alliance including Marc Horner, International Affairs WG leader, Martha de Cuhna, Policy Development WG Leader, and our new partner Surash Surash from the leading Notified Body TüV SüD, spoke at the Regulatory Affairs Professional Society (RAPS) meeting in Pittsburgh to highlight the essential and increasing role of in silico methods throughout the total product life cycle of medical devices.
Avicenna Alliance Welcomes the Notified Body TÜV SÜD as a New Partner
The Avicenna Alliance is delighted to welcome TÜV SÜD as its newest Partner. TÜV SÜD is a leading Notified Body operating across multiple regulatory territories, including the EU, the United States, the UK, and Asia. With more than 150 years of experience, a presence in 1,000 locations worldwide, and over 30,000 employees, TÜV SÜD is a trusted global partner in testing, inspection, certification, and training solutions.
The Alliance at the iSi Health Symposium
On 11 and 12 September 2025, our partner iSi Health, Erica Beaucage-Gauvreau and Rocio Castro Vinuelas, organised an excellent symposium in Leuven to bring together key players in the in silico community and promote networking, brainstorming and exchanges.
